Ticker > Company >

Hamps Bio share price

Hamps Bio Ltd.

BSE: 544312 SECTOR: Trading  4.72 K   2   0

30.00
+0.58 (1.97%)
BSE: 05 Sep 4:00 PM

Price Summary

Today's High

₹ 30.01

Today's Low

₹ 30

52 Week High

₹ 53.6

52 Week Low

₹ 17.11

FinStar is Suspended!

The FinStar rating for this company is currently unavailable due to limited data disclosure. As a micro-cap company, it may carry higher risk and limited transparency. We will update the FinStar rating once more reliable data becomes available.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

26.14 Cr.

Enterprise Value

29.01 Cr.

No. of Shares

0.87 Cr.

P/E

87.8

P/B

1.48

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  20.2

CASH

0.1 Cr.

DEBT

2.97 Cr.

Promoter Holding

71.99 %

EPS (TTM)

₹  0.34

Sales Growth

2.99%

ROE

4.9 %

ROCE

6.73%

Profit Growth

-40.53 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year2.99%
3 Year7.68%
5 YearNA

Profit Growth

1 Year-40.53%
3 Year34.81%
5 YearNA

ROE%

1 Year4.9%
3 Year18.83%

ROCE %

1 Year6.73%
3 Year15.15%

Debt/Equity

0.3372

Price to Cash Flow

-14.78

Interest Cover Ratio

3.8946

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2025 71.99 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has an efficient Cash Conversion Cycle of 74.7593 days.
  • Company has a healthy liquidity position with current ratio of 2.2635.
  • The company has a high promoter holding of 71.99%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 3.56087280740052.

 Limitations

  • The company has shown a poor revenue growth of 7.68493154169776% for the Past 3 years.
  • Company has negative cash flow from operations of -1.7682.
  • The company has a low EBITDA margin of 0% over the past 5 years.
  • The company is trading at a high PE of 87.8.
  • The company is trading at a high EV/EBITDA of 31.5162.

Quarterly Result (All Figures in Cr.)

 Quarterly Data is not available for this company.Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 5.34 5.58 6.48 6.67
Total Expenditure 4.73 4.71 5.3 5.9
Operating Profit 0.62 0.87 1.18 0.77
Other Income 0 0.01 0.03 0.15
Interest 0.19 0.18 0.15 0.14
Depreciation 0.33 0.34 0.4 0.38
Exceptional Items 0 0 0 0
Profit Before Tax 0.1 0.36 0.65 0.4
Tax -0.02 0 0.15 0.11
Net Profit 0.12 0.36 0.5 0.3
Adjusted EPS (Rs.) 0.51 1.5 1.6 0.68

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 1.5 1.5 1.96 4.36
Total Reserves -0.49 -0.14 1.38 4.44
Borrowings 0.79 0.48 0.3 2.03
Other N/C liabilities 0.01 0.01 0.01 0.02
Current liabilities 1.8 2.07 1.4 1.87
Total Liabilities 3.61 3.92 5.05 12.72
Assets
Net Block 2.15 2.61 2.52 2.48
Capital WIP 0 0 0 3.28
Intangible WIP 0 0 0 0.11
Investments 0.04 0 0 0
Loans & Advances 0.09 0.08 0.09 0.23
Other N/C Assets 0 0 0 2.39
Current Assets 1.33 1.23 2.44 4.24
Total Assets 3.61 3.92 5.05 12.72
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 0.12 0.36 0.65 0.4
Adjustment 0.5 0.51 0.5 -0.59
Changes in Assets & Liabilities -0.28 0.36 -1.29 -1.47
Tax Paid 0 0 -0.15 -0.11
Operating Cash Flow 0.33 1.23 -0.29 -1.77
Investing Cash Flow 0.51 -0.75 -0.37 -6.2
Financing Cash Flow -0.94 -0.48 0.67 8
Net Cash Flow -0.1 0 0.01 0.04

Corporate Actions

Investors Details

PARTICULARS Mar 2025%
promoters 71.99
alkaben mountbaton shah 0.10
bhavya herrik shah 1.47
herrik mountbaton shah 31.12
herrik mountbaton shah hu... 5.27
mitali shrenikkumar shah 0.73
mountbaton s shah huf 3.42
pallavi herrik shah 3.38
shrenik mountkumar shah 23.56
shrenik mountkumar shah h... 2.94
PARTICULARS Mar 2025%
investors 28.01
anil gurmukh bhagwani 1.56
narayanan ottappath 2.30

Annual Reports

Title Link
Title Link
 No Annual reports exist for this company.Report us

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit and Research reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation and Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Hamps Bio Stock Price Analysis and Quick Research Report. Is Hamps Bio an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Hamps Bio. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Hamps Bio has a PE ratio of 87.7963125548727 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Hamps Bio has ROA of 3.3489% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Hamps Bio has a Current ratio of 2.2635.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Hamps Bio has a ROE of 4.9025%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Hamps Bio has a Debt to Equity ratio of 0.3372 which means that the company has low proportion of debt in its capital.

  • Sales growth: Hamps Bio has reported revenue growth of 2.9883% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Hamps Bio for the current financial year is 11.5358085412668%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Hamps Bio is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Hamps Bio is Rs 0.3417. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Hamps Bio in Ticker for free. Also, one can get the intrinsic value of Hamps Bio by using Valuation Calculators, which are available with a Finology ONE subscription. 

Hamps Bio FAQs

Q1. What is Hamps Bio share price today?
Ans: The current share price of Hamps Bio is Rs 30.

Q2. What is the market capitalisation of Hamps Bio?
Ans: Hamps Bio has a market capitalisation of Rs 26.136 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Hamps Bio?
Ans: The PE ratio of Hamps Bio is 87.7963125548727 and the P/B ratio of Hamps Bio is 1.48491328106439, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Hamps Bio share?
Ans: The 52-week high share price of Hamps Bio is Rs 53.6, and the 52-week low share price of Hamps Bio is Rs 17.105.

Q5. Does Hamps Bio pay dividends?
Ans: Currently, Hamps Bio does not pay dividends. Dividend yield of Hamps Bio is around 0%.

Q6. What are the face value and book value of Hamps Bio shares?
Ans: The face value of Hamps Bio shares is Rs 10, while the book value per share of Hamps Bio is around Rs 20.2032. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Hamps Bio?
Ans: Hamps Bio has a total debt of Rs 2.9672 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Hamps Bio?
Ans: The ROE of Hamps Bio is 4.9025% and ROCE of Hamps Bio is 6.7251%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Hamps Bio a good buy for the long term?
Ans: The Hamps Bio long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Hamps Bio undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Hamps Bio appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Hamps Bio’s financials?
Ans: You can review Hamps Bio’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Hamps Bio
X